Tango Therapeutics, Inc. — All Filings
360 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001178937-25-000037 | Sep 17, 2025 | — |
| 4 | 4 | 0001193125-25-199177 | Sep 9, 2025 | Sep 5, 2025 |
| 144 | — | 0001178937-25-000034 | Sep 8, 2025 | — |
| 144 | — | 0001178937-25-000033 | Sep 5, 2025 | — |
| 4 | 4 | 0000950170-25-111457 | Aug 26, 2025 | Aug 22, 2025 |
| 8-K | 8-K | 0001193125-25-187680 | Aug 25, 2025 | Aug 21, 2025 |
| 144 | — | 0001178937-25-000032 | Aug 22, 2025 | — |
| 4 | 4 | 0000950170-25-110662 | Aug 21, 2025 | Aug 19, 2025 |
| 144 | — | 0001178937-25-000030 | Aug 19, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003592 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000908834-25-000242 | Aug 13, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003513 | Aug 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-102387 | Aug 5, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-102392 | Aug 5, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0002052113-25-003135 | Jul 17, 2025 | — |
| SCHEDULE 13G | — | 0000908834-25-000200 | Jun 13, 2025 | — |
| 4 | 4 | 0000950170-25-083912 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083903 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083906 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083907 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083911 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0001193125-25-137032 | Jun 6, 2025 | Jun 5, 2025 |
| EFFECT | — | 9999999995-25-001696 | May 21, 2025 | — |
| UPLOAD | — | 0000000000-25-005336 | May 20, 2025 | — |
| CORRESP | — | 0001193125-25-122432 | May 19, 2025 | — |
| 8-K | 8-K | 0000950170-25-068546 | May 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-068549 | May 12, 2025 | Mar 31, 2025 |
| S-3 | S-3 | 0001193125-25-117922 | May 12, 2025 | — |
| DEFR14A | DEFR14A | 0000950170-25-057632 | Apr 24, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-089323 | Apr 22, 2025 | — |
| ARS | ARS | 0001193125-25-089325 | Apr 22, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-056230 | Apr 21, 2025 | — |
| PRE 14A | PRE 14A | 0000950170-25-053024 | Apr 11, 2025 | — |
| 8-K | 8-K | 0000950170-25-028345 | Feb 27, 2025 | Aug 10, 2022 |
| 10-K | 10-K | 0000950170-25-028353 | Feb 27, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001193125-25-037611 | Feb 27, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000161 | Feb 14, 2025 | — |
| 4 | 4 | 0000950170-25-015704 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | 4 | 0000950170-25-015696 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | 4 | 0000950170-25-015684 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | 4 | 0000950170-25-015693 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | 4 | 0000950170-25-014808 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-014810 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-014813 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-014840 | Feb 5, 2025 | Feb 3, 2025 |
| 8-K | 8-K | 0001193125-25-004977 | Jan 13, 2025 | — |
| SCHEDULE 13D/A | — | 0000895345-25-000001 | Jan 2, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-24-002974 | Dec 6, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-262550 | Nov 20, 2024 | — |
| 4 | 4 | 0000950170-24-128163 | Nov 18, 2024 | Nov 14, 2024 |